Evotec International Overview
- Year Founded
-
1997
- Status
-
Acquired/Merged
- Employees
-
472
- Latest Deal Type
-
Corporate
- Latest Deal Amount
-
$257K
Evotec International General Information
Description
Manufacturer of biopharmaceutical products. The company develops therapies for metabolic disorders based on model organisms and stem cell expertise.
Contact Information
Website
evotecoai.comCorporate Office
- Marie-Curie-Strasse 7
- 37079 Gottingen
- Germany
Corporate Office
- Marie-Curie-Strasse 7
- 37079 Gottingen
- Germany
Evotec International Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Corporate | 24-Jan-2012 | $257K | Completed | Generating Revenue | ||
| 5. Merger/Acquisition | 03-Sep-2010 | Completed | Generating Revenue | |||
| 4. Grant | 23-Feb-2010 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 17-May-2004 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 18-Apr-2001 | $35.6M | $38.6M | Completed | Startup | |
| 1. Early Stage VC | 01-Dec-1997 | $3M | $3M | Completed | Product Development |
Evotec International Patents
Evotec International Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026209601-A1 | Nlrp3 modulators | Pending | 31-Mar-2025 | ||
| WO-2026131684-A1 | Low-dose x-ray irradiation for the elimination of unwanted cell growth in pluripotent stem cell-derived islet-like clusters | Pending | 16-Dec-2024 | ||
| WO-2026114926-A1 | Prodrugs of nlrp3 modulators | Pending | 29-Nov-2024 | ||
| WO-2026046953-A1 | Methods of pluripotent stem cell expansion | Pending | 28-Aug-2024 | ||
| EP-4684808-A1 | Plasmids, transgenes, vectors and medical uses comprising adamts13 | Pending | 22-Jul-2024 | A61K48/005 |
Evotec International Signals
Evotec International Former Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Allianz Specialized Investments | Venture Capital | Minority | ||
| Atlas Venture | Venture Capital | Minority | ||
| Aventis | Corporation | Minority | ||
| CBG Commerz Beteiligungskapital | Mezzanine | Minority | ||
| Carlyle AlpInvest | PE/Buyout | Minority |
Evotec International Acquisitions (1)
Evotec International’s most recent deal was a Merger/Acquisition with Peptor for . The deal was made on 17-May-2004.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Peptor | 17-May-2004 | Merger/Acquisition | Biotechnology |
Evotec International Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| NephThera | Hamburg, Germany | 2019 |
Evotec International FAQs
-
When was Evotec International founded?
Evotec International was founded in 1997.
-
Where is Evotec International headquartered?
Evotec International is headquartered in Gottingen, Germany.
-
What is the size of Evotec International?
Evotec International has 472 total employees.
-
What industry is Evotec International in?
Evotec International’s primary industry is Drug Discovery.
-
Is Evotec International a private or public company?
Evotec International is a Private company.
-
What is the current valuation of Evotec International?
The current valuation of Evotec International is .
-
What is Evotec International’s current revenue?
The current revenue for Evotec International is .
-
How much funding has Evotec International raised over time?
Evotec International has raised $257K.
-
Who are Evotec International’s investors?
Allianz Specialized Investments, Atlas Venture, Aventis, CBG Commerz Beteiligungskapital, and Carlyle AlpInvest are 5 of 16 investors who have invested in Evotec International.
-
When was Evotec International acquired?
Evotec International was acquired on 24-Jan-2012.
-
Who acquired Evotec International?
Evotec International was acquired by Evotec.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process